BofA Raises Merck (MRK) Price Target to $105, Keeps Buy Rating
Big Pharma Boost: BofA Raises Price Target on Merck, Citing Strong Pipeline and Blockbuster Sales It’s been a good month for pharmaceutical giant Merck (MRK), and Wall Street is taking notice. In a significant vote of confidence, Bank of America Securities recently boosted its price target for the company’s stock to $105, while maintaining a…